Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey ,
, Br J Clin Pharmacol, vol.64, pp.198-209, 2007.
Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia, Drugs, vol.59, pp.865-889, 2000. ,
Abuse potential during use and withdrawal psychosis after treatment with the hypnotic zolpidem ,
, Ugeskr Laeg, vol.155, pp.2711-2713, 1993.
An update on zolpidem abuse and dependence, J Addict Dis, vol.33, pp.15-23, 2014. ,
Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion, Fundam Clin Pharmacol, vol.32, pp.306-322, 2018. ,
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, pp.954-962, 2017. ,
French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol, BMJ Open, vol.9, p.31256026, 2019. ,
Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots, Addict Behav, vol.39, pp.1176-1182, 2014. ,
, Le Pharmacien Hospitalier et Clinicien, vol.53, issue.4, pp.288-300, 2018.
Consequences of the new zolpidem prescription regulations: a cohort study from the French national healthcare database, Eur J Clin Pharmacol, p.31608425, 2019. ,
, Mandatory prescription of zolpidem on secure prescription-Enquiry Point-ANSM: National Agency for the Safety of Medicines and Health Products, p.6, 2020.
new prescribing and dispensing conditions-Dear Healthcare Professional Letter-ANSM: National Agency for the Safety of Medicines and Health Products, p.6, 2020. ,
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage, New prescription rules halved zolpidem use in France PLOS ONE, vol.69, pp.1965-1972, 2013. ,
How long are consultations in French general practice?, European Journal of General Practice, vol.6, pp.88-92, 2000. ,
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications, Pharmacoepidemiol Drug Saf, vol.26, pp.712-721, 2017. ,
Responsiveness and communication of pharmacovigilance decisions from health authorities to health professionals: examples of pergolide and celecoxib, Therapies, vol.62, pp.513-517, 2007. ,
Management of benzodiazepine misuse and dependence, Aust Prescr, vol.38, pp.152-155, 2015. ,
How a novel programme for increasing awareness of health professionals resulted in a 14% decrease in patients using excessive doses of psychotropic drugs in western France, Eur J Clin Pharmacol, vol.62, p.16506046, 2006. ,
, , p.6, 2017.
Z-Drug" Dependence: Data From a Tertiary Care Center, Prim Care Companion CNS Disord, vol.19, pp.0-0, 2017. ,
Gender differences in prescribing of zolpidem in the Veterans Health Administration, Am J Manag Care, vol.25, pp.58-65, 2019. ,
Zolpidem abuse and dependency in an elderly patient with major depressive disorder: a case report, Daru, vol.22, p.54, 2014. ,
Zolpidem dependence in a geriatric patient: a case report, J Am Geriatr Soc, vol.57, pp.1962-1963, 2009. ,
, Therapie, vol.58, pp.425-430, 2003.
An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions, Int J Neuropsychopharmacol, vol.22, pp.270-277, 2019. ,
Twelve-year trend in the use of zolpidem and physicians' non-compliance with recommended duration: a Korean national health insurance database study, Eur J Clin Pharmacol, vol.75, p.30280207, 2019. ,
Chronic hypnotic use at 10 years-does the brand matter?, Eur J Clin Pharmacol, vol.74, p.30090968, 2018. ,
Mass media interventions: effects on health services utilisation, Cochrane Database Syst Rev, vol.000389, 2000. ,
Using media to impact health policy-making: an integrative systematic review, Implement Sci, vol.12, p.28420401, 2017. ,
Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative Analysis, J Health Commun, vol.22, pp.365-372, 2017. ,